Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.

Lindl KA, Marks DR, Kolson DL, Jordan-Sciutto KL.

J Neuroimmune Pharmacol. 2010 Sep;5(3):294-309. doi: 10.1007/s11481-010-9205-z. Epub 2010 Apr 16. Review.

PMID:
20396973
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

HIV-1-associated central nervous system dysfunction.

Krebs FC, Ross H, McAllister J, Wigdahl B.

Adv Pharmacol. 2000;49:315-85. Review.

PMID:
11013768
[PubMed - indexed for MEDLINE]
3.

HIV-associated dementia: new insights into disease pathogenesis and therapeutic interventions.

Swindells S, Zheng J, Gendelman HE.

AIDS Patient Care STDS. 1999 Mar;13(3):153-63. Review.

PMID:
10375263
[PubMed - indexed for MEDLINE]
4.

HIV-1 neuroimmunity in the era of antiretroviral therapy.

Kraft-Terry SD, Stothert AR, Buch S, Gendelman HE.

Neurobiol Dis. 2010 Mar;37(3):542-8. doi: 10.1016/j.nbd.2009.12.015. Epub 2010 Jan 4. Review.

PMID:
20044002
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches.

Kaul M.

Curr Opin Neurol. 2009 Jun;22(3):315-20. doi: 10.1097/WCO.0b013e328329cf3c. Review.

PMID:
19300249
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

HIV-associated neurological disorders: a guide to pharmacotherapy.

Tan IL, McArthur JC.

CNS Drugs. 2012 Feb 1;26(2):123-34. doi: 10.2165/11597770-000000000-00000. Review.

PMID:
22201342
[PubMed - indexed for MEDLINE]
7.

HIV-1 infection and neurocognitive impairment in the current era.

del Palacio M, Alvarez S, Muñoz-Fernández MÁ.

Rev Med Virol. 2012 Jan;22(1):33-45. doi: 10.1002/rmv.711. Epub 2011 Sep 23. Review.

PMID:
21990255
[PubMed - indexed for MEDLINE]
8.

Current understanding of HIV-associated neurocognitive disorders pathogenesis.

Gannon P, Khan MZ, Kolson DL.

Curr Opin Neurol. 2011 Jun;24(3):275-83. doi: 10.1097/WCO.0b013e32834695fb. Review.

PMID:
21467932
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments.

Gray F, Adle-Biassette H, Chretien F, Lorin de la Grandmaison G, Force G, Keohane C.

Clin Neuropathol. 2001 Jul-Aug;20(4):146-55. Review.

PMID:
11495003
[PubMed - indexed for MEDLINE]
10.

Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus.

Bogoch II, Davis BT, Venna N.

J Infect. 2011 Sep;63(3):236-9. doi: 10.1016/j.jinf.2011.05.011. Epub 2011 May 25.

PMID:
21658774
[PubMed - indexed for MEDLINE]
11.

Neurological disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.

Wright EJ.

Curr Opin HIV AIDS. 2009 Sep;4(5):447-52. doi: 10.1097/COH.0b013e32832dd0c2. Review.

PMID:
20048710
[PubMed - indexed for MEDLINE]
12.
13.

HIV, antiretroviral therapies, and the brain.

Liner KJ 2nd, Ro MJ, Robertson KR.

Curr HIV/AIDS Rep. 2010 May;7(2):85-91. doi: 10.1007/s11904-010-0042-8. Review.

PMID:
20425562
[PubMed - indexed for MEDLINE]
14.

Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS.

Kaul M, Lipton SA.

J Neuroimmune Pharmacol. 2006 Jun;1(2):138-51. Review.

PMID:
18040780
[PubMed - indexed for MEDLINE]
15.

Dementia and neurocognitive disorders due to HIV-1 infection.

Ances BM, Ellis RJ.

Semin Neurol. 2007 Feb;27(1):86-92. Review.

PMID:
17226745
[PubMed - indexed for MEDLINE]
16.

Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis.

Hu S, Sheng WS, Rock RB.

J Neuroimmune Pharmacol. 2011 Dec;6(4):528-39. doi: 10.1007/s11481-011-9306-3. Epub 2011 Aug 18. Review.

PMID:
21850403
[PubMed - indexed for MEDLINE]
17.

Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.

Cohen RA, Harezlak J, Schifitto G, Hana G, Clark U, Gongvatana A, Paul R, Taylor M, Thompson P, Alger J, Brown M, Zhong J, Campbell T, Singer E, Daar E, McMahon D, Tso Y, Yiannoutsos CT, Navia B.

J Neurovirol. 2010 Feb;16(1):25-32. doi: 10.3109/13550280903552420.

PMID:
20113183
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Rodent models for HIV-associated neurocognitive disorders.

Gorantla S, Poluektova L, Gendelman HE.

Trends Neurosci. 2012 Mar;35(3):197-208. doi: 10.1016/j.tins.2011.12.006. Epub 2012 Feb 1. Review.

PMID:
22305769
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs.

Bell JE, Arango JC, Anthony IC.

J Neuroimmune Pharmacol. 2006 Jun;1(2):182-91. Epub 2006 May 5. Review.

PMID:
18040783
[PubMed - indexed for MEDLINE]
20.

Antiretroviral therapy and central nervous system HIV type 1 infection.

Price RW, Spudich S.

J Infect Dis. 2008 May 15;197 Suppl 3:S294-306. doi: 10.1086/533419. Review.

PMID:
18447615
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk